Son who was treated for leukaemia inspires family’s fundraising and bid to raise awareness
A family whose son was treated for leukaemia is raising awareness of the disease and funds for research into improving treatments for it.
Ezra's story
Ezra was diagnosed with medulloblastoma, when six years old in June 2024. His mum, Rhiannon, shares his story.
CCLG Research Talks: How did children and families help set childhood cancer research priorities?
Susie Aldiss talks about the top ten research priorities in childhood cancer and what's next for this project.
How listening to parents is shaping lymphoma research, with Professor Suzanne Turner
Hear from Professor Suzanne Turner about her research and how families are at its heart.
Little Princess Trust funding boosts brain tumour research
CCLG: The Children & Young People’s Cancer Association has supported The Little Princess Trust (LPT) in funding two new research projects that aim to improve treatment and care for children and people with brain tumours.
Dad to take on Great North Run in memory of son
A father is taking part in the Great North Run to raise funds for children’s cancer research in memory of his two-year-old son.
Could it be cancer? National awareness campaign urges parents to trust their instincts on childhood symptoms
A new childhood cancer awareness campaign, Child Cancer Smart, has been launched today by CCLG: The Children & Young People’s Cancer Association and researchers at the University of Nottingham aiming to speed up diagnosis and improve survival for children and teenagers with cancer.
New discovery links circular DNA by-products to childhood leukaemia relapse
A Little Princess Trust-funded research project has found that a previously overlooked type of circular DNA may explain why some children with leukaemia relapse.
New research aims to understand and fight the mechanisms of Ewing sarcoma
CCLG: The Children & Young People’s Cancer Association is proud to be one of four charities co-funding a new research project that could pave the way to more effective and targeted treatments for a rare and aggressive type of bone cancer.